| 000 | 01632 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515185931.0 | ||
| 264 | 0 | _c20100614 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1573-2592 | ||
| 024 | 7 |
_a10.1007/s10875-009-9325-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWong, C K | |
| 245 | 0 | 0 |
_aElevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. _h[electronic resource] |
| 260 |
_bJournal of clinical immunology _cJan 2010 |
||
| 300 |
_a45-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntigens, CD _xbiosynthesis |
| 650 | 0 | 4 |
_aB-Cell Activating Factor _xbiosynthesis |
| 650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCell Movement _ximmunology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aChemokine CXCL13 _xbiosynthesis |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukins _xbiosynthesis |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptors, CXCR5 _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Interleukin-21 _xgenetics |
| 650 | 0 | 4 | _aInterleukin-21 |
| 700 | 1 | _aWong, Purple T Y | |
| 700 | 1 | _aTam, L S | |
| 700 | 1 | _aLi, Edmund K | |
| 700 | 1 | _aChen, D P | |
| 700 | 1 | _aLam, Christopher W K | |
| 773 | 0 |
_tJournal of clinical immunology _gvol. 30 _gno. 1 _gp. 45-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10875-009-9325-5 _zAvailable from publisher's website |
| 999 |
_c19171411 _d19171411 |
||